Drug Type Blood components |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Alkahest, Inc.Startup |
Active Organization- |
Inactive Organization Alkahest, Inc.Startup |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Phase 2 | US | Alkahest, Inc.Startup | 05 Sep 2021 |
Parkinson Disease | Phase 2 | US | Alkahest, Inc.Startup | 05 Sep 2021 |